Ignite Creation Date:
2025-12-25 @ 4:25 AM
Ignite Modification Date:
2025-12-26 @ 3:28 AM
Study NCT ID:
NCT06678620
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-17
First Post:
2024-11-05
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase II Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine
Sponsor:
Shanghai Reinovax Biologics Co.,LTD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-20
Start Date Type:
ACTUAL
Primary Completion Date:
2025-04-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-03
Completion Date Type:
ESTIMATED
First Submit Date:
2024-11-05
First Submit QC Date:
None
Study First Post Date:
2024-11-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-15
Last Update Post Date:
2025-12-17
Last Update Post Date Type:
ESTIMATED